[1]
M. O. Dolinna and O. O. Svyntozelskyi, “Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis”, Curr. Issues Pharm. Med. Sci., vol. 33, no. 1, pp. 17–20, Mar. 2020, doi: 10.2478/cipms-2020-0005.